HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emanuela Ognio Selected Research

1,4- bis(1- naphthyl)- 2,3- dinitro- 1,3- butadiene

12/2007Naphthylnitrobutadienes as pharmacologically active molecules: evaluation of the in vivo antitumour activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emanuela Ognio Research Topics

Disease

10Neoplasms (Cancer)
01/2018 - 09/2005
2Necrosis
11/2014 - 04/2009
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2012 - 10/2010
2Neuroblastoma
02/2012 - 11/2007
2Melanoma (Melanoma, Malignant)
07/2009 - 03/2007
2Experimental Melanoma
12/2007 - 03/2007
1Inflammation (Inflammations)
01/2020
1Sepsis (Septicemia)
01/2020
1Amyloid Plaque
01/2020
1Amyloidosis
01/2020
1Cryopyrin-Associated Periodic Syndromes
01/2020
1B-Cell Lymphoma (Lymphoma, B Cell)
10/2015
1Communicable Diseases (Infectious Diseases)
10/2015
1Prostatic Neoplasms (Prostate Cancer)
11/2014
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
08/2014
1Leukemia
03/2012
1Hemolysis
02/2012
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
11/2010
1Multiple Myeloma
08/2010
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2009
1Malignant Mesothelioma
10/2008
1Plasmacytoma
08/2008
1Lymphoma (Lymphomas)
08/2008
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
08/2008
1Colonic Neoplasms (Colon Cancer)
12/2007
1Lewis Lung Carcinoma
12/2007
1Fibrosarcoma
12/2007
1Fetal Weight
12/2006
1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell)
04/2006
1Wounds and Injuries (Trauma)
09/2005
1Stomach Neoplasms (Stomach Cancer)
09/2005

Drug/Important Bio-Agent (IBA)

4CytokinesIBA
01/2020 - 10/2010
4Interleukin-12 (IL 12)IBA
10/2010 - 04/2006
3Interleukin-27 (Interleukin 27)IBA
11/2014 - 08/2010
3Pharmaceutical PreparationsIBA
02/2012 - 09/2005
2Vascular Endothelial Growth Factor CIBA
01/2018 - 10/2010
2Antineoplastic Agents (Antineoplastics)IBA
11/2010 - 08/2010
1Proton Pump InhibitorsIBA
01/2020
1NLR ProteinsIBA
01/2020
1Interleukin-17 (Interleukin 17)IBA
10/2015
1AndrogensIBA
08/2014
1Annexin A5IBA
03/2012
1Bromodeoxyuridine (BrdU)IBA
03/2012
1Propidium (Propidium Iodide)IBA
03/2012
1FenretinideIBA
02/2012
1Interleukin-23 (Interleukin 23)IBA
11/2010
1Interleukin-8 (Interleukin 8)IBA
10/2010
1Interleukin-6 (Interleukin 6)IBA
10/2010
1CD13 Antigens (Alanine Aminopeptidase)IBA
10/2010
1Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
07/2009
1AgarIBA
07/2009
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
07/2009
1Caspase 9IBA
07/2009
1Adapalene (Differin)FDA LinkGeneric
07/2009
1dichlobanilIBA
04/2009
1HerbicidesIBA
04/2009
1methyl 2- methylsulfanyl- 5- (1- naphthyl)- 4- nitro- 2,4- pentadienoateIBA
12/2007
11,4- bis(1- naphthyl)- 2,3- dinitro- 1,3- butadieneIBA
12/2007
1Cisplatin (Platino)FDA LinkGeneric
12/2006
1Procainamide (Procan)FDA LinkGeneric
12/2006
1Messenger RNA (mRNA)IBA
04/2006
1Proteins (Proteins, Gene)FDA Link
04/2006
1IronIBA
09/2005
1Fluorouracil (Carac)FDA LinkGeneric
09/2005
1GemcitabineFDA Link
09/2005
1Oxaliplatin (Eloxatin)FDA LinkGeneric
09/2005
1Irinotecan (Camptosar)FDA LinkGeneric
09/2005

Therapy/Procedure

3Therapeutics
03/2012 - 11/2007
1Drug Therapy (Chemotherapy)
02/2012
1Intravenous Administration
02/2012
1Immunotherapy
11/2007